Definitive Contract HHSD200201792634C
Award Date 12/8/16
Potential Completion Date 6/30/22
Potential Value $1.2B
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lansing, MI 48906, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $99,941,719.80 definitive, firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense, on March 16, 2017. The contract has an ultimate completion date of March 15, 2019 and is not set aside. Emergent Biodefense is a for-profit manufacturer of medical countermeasures and biopharmaceuticals, specializing in vaccines and therapeutics for public health...
- The U.S. Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Emergent Biodefense Operations Lansing LLC a $66.9 million firm fixed-price delivery order on January 4, 2026, for the procurement of BioThrax (Anthrax Vaccine Absorbed). The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2029, with manufacturing and delivery operations based in Lansing, Michigan. This delivery order is issued under an...
- This federal contract award is for BAXTER CELL HARVEST services in year 6 of the contract, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense. The contract has a ceiling value of $38,250,000.00 and was awarded on September 30, 2016, with an ultimate completion date of August 31, 2018. It is a Firm Fixed Price delivery order contract. Emergent Biodefense is a for-profit manufacturer of...
- This is a $43,794,113.43 cost-plus-fixed-fee definitive contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit manufacturer, for the advanced development of NuThrax (Anthrax Vaccine Absorbed with CPG 7909) or AV7909. The contract has an ultimate completion date of July 31, 2019 and was awarded on March 23, 2015. There is no set-aside designation for this...
- The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $79,947,200.00 Firm Fixed Price contract to Elusys Therapeutics Inc. for the manufacture and vendor managed inventory of Anthim (obiltoxaximab) 600mg/6ml for Injection, an FDA-approved anthrax antitoxin. The contract has a period of performance from August 6, 2021 through September 14, 2024, and includes options for additional manufacturing and delivery of finished drug...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a Firm Fixed Price Purchase Order contract to Emergent Biodefense Operations Lansing LLC for the WETVAX 2021 project. The contract has a potential value of $141,400.00 and a completion date of August 31, 2021. The contract does not have a set-aside designation. Emergent Biodefense Operations Lansing LLC is the prime contractor for this award, which is likely related to the agency's...
- <p>This is a Cost Plus Fixed Fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Altimmune, Inc. for the development of a single-dose intranasal vaccine for post-exposure prophylaxis of inhalation anthrax. The award has a ceiling value of $135,880,962.00 and a period of performance through December 31, 2021. The contract was awarded on July 27, 2016 and does not have a set-aside designation.</p>
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Emergent Product Development Gaithersburg Inc. a firm fixed price contract valued at $804.9 million on August 30, 2019, for the manufacture and delivery of ACAM2000, a live vaccinia smallpox vaccine. The contract, which extends through August 29, 2029, supports the federal government's medical countermeasures stockpiling and pandemic preparedness initiatives. Work will be...
- <p>This is a contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Emergent Biodefense Operations Lansing LLC, also known as Emergent Biodefense, for the maintenance of a smallpox license. The contract is a delivery order with a firm fixed price of $38,430,000.00 and a completion date of January 31, 2019. The place of performance is located in Cambridge, Massachusetts. The contract does not have a set-aside designation.</p>
- The Office of the Assistant Secretary for Preparedness and Response awarded a $124.5 million firm fixed-price definitive contract to Elusys Therapeutics Inc. on May 1, 2024, for the supply and delivery of ANTHIM (obiltoxaximab), a monoclonal antitoxin therapeutic. The contract, which extends through December 31, 2028, is being performed at the contractor's facility in Parsippany, New Jersey. This award reflects the federal government's commitment to maintaining strategic medical...